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Abstract Diclofenac is the world known nonsteroidal anti-
inflammatory drug (NSAID) predicted before its syntesis
on the basis of the model COX enzyme. Due to its spe-
cific structural properties the drug possesses high reactivity
and outstanding tolerability. Among the key features defin-
ing the diclofenac structure is intramolecular N-H· · · O
hydrogen bond confirmed during the X-ray analysis. In the
present research we use static DFT calculations, the Quan-
tum Theory of Atoms in Molecules and non-covalent inter-
actions (NCI) index to confirm the additional intramolecular
interactions, which influence the drug molecular structure.
We focus on the structural stability of diclofenac as the
result of the hydrogen bonds breaking/formation at finite
temperature utilizing ab initio molecular dynamics simu-
lations. The lifetime of different intramolecular hydrogen
bonds is estimated. We perform also the comparative anal-
ysis of the structural stability of ibuprofen and ketopro-
fen molecules in the gas phase at 300 K with respect to
diclofenac in terms of the NSAID inhibition activity. Due to
the detailed description of diclofenac intramolecular inter-
actions, possible drug modifications for its enhanced water
solubility can be suggested.
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Introduction
Among the most widely prescribed nonsteroidal anti-
inflammatory drug (NSAID) products, diclofenac (DCL)
ranks at the first place [1]. It is known as an effective
cyclooxygenase (COX) inhibitor with anti-inflammatory,
analgetic and antipyretic properties [2] with the best inhi-
bition activity of the COX-2 enzyme [3], comparing with
other NSAIDs, non-selective to this enzyme. Recently, DCL
treatment was found to have even an anti-cancer effects [4].
The history of diclofenac (DCL) started at early 70s
when, on the basis of both experimental and clinical find-
ings, the features of an ideal nonsteroidal anti-inflammatory
drug were postulated [5–8]. They said that an effec-
tive antirheumatic agent should have an acidity constant
between 4 and 5, a partition coefficient (octanol/water at
pH 7.4) of c.a. 10, and two aromatic rings maximally
twisted in relation to each other [8]. Several factors were
taken into account during the mentioned analysis: (i) drug
transport through biologic membranes, (ii) the atomic and
spatial structure of the molecule to fit the COX receptor,
and (iii) the electronic structure, which controls the specific
interaction between the drug and the receptor. Among more
than 200 NSAID agents tested [8], including 36 congeners
of diclofenac [9], DCL (with an acidity constant of 4.0 and a
partition coefficient of 13.4) was found to possess the most
interesting pharmacologic properties caused as the result of
the specific structure.
DCL molecule consists of two aromatic rings: the pheny-
lacetic and chlorine functionalized, and the secondary
amino group, which is their linkage (see Fig. 1). As the
result of the repulsion interations between the acetate group
and the Cl atoms, the aromatic rings are twisted with
respect to each other (the angle of twist is about 69° [8]),
what enables the DCL specific interactions with the COX
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Fig. 1 Structural formulae of
the analyzed NSAID: diclofenac
(a), ketoprofen (b) and
ibuprofen (c)
enzyme [7]. Moreover, such arrangement of the DCL phenyl
rings provide a good fit in the substrate-binding pocket of
the COX increasing its inhibition activity [5, 10]. Apart from
the mentioned DCL structural feature, its secondary amino
group participates in a bifurcated intramolecular hydrogen
bond, interacting with the carbonyl oxygen and the chlo-
rine atoms [9, 11]. The existence of N-H· · · Cl H-bond was
confirmed only in the X-ray analysis [11] and this weak
type of interactions is rarely taken into consideration dur-
ing the experimental investigation of DCL. In contrast, the
N-H· · · O H-bond is mentioned as characteristic intramolec-
ular DCL hydrogen bond [8, 9, 12]. N-H· · · O attractive
interaction is known as strong (resonance-assisted) hydro-
gen bond [13]. The structural parameters of intramolecular
N-H· · · O H-bond for β-ketoarylhydrazones are in the range
of 1.76–2.32 A˚ and 99–140° for the H· · · O distance and
NHO angle, respectively [14]. Simultaneously, the energy
of this H-bond can equal even 60 kJ/mol.
Since, similarly to other NSAID, diclofenac therapy
causes gastrointestinal, cardiovascular and renal adverse
effects [15, 16], a lot of different DCL-containing drug
products are developed [17] to improve the drug efficacy,
tolerability and patient convenience. The existence of the
mentioned intramolecular N-H· · · O H-bond in DCL is uti-
lized to modify the drug with, e.g., transition metals [18–
20], cyclodextrin [21] or PEG [22], to increase its water
solubility and oral bioavailability. Up to now, no research
on the N-H· · · O dynamics at finite temperature was made.
Since this H-bond is crucial either during DCL modification
or in the COX inhibion, we are focused on its detailed analy-
sis utilizing both static DFT calculations and Car–Parrinello
molecular dynamics simulations.
The DCL specific structure is caused not only by N-
H· · · O H-bond, but also by other intramolecular interac-
tions, e.g. N-H· · · Cl, O-H· · · N H-bonds, vdW interactions
and steric clashes. Their mutual interplay defines the drug
structural stability and inhibition activity. As it was not stud-
ied before, in the present work the systematic study on the
DCL structural rearrangements and intramolecular interac-
tions at 300 K are investigated with the direct comparison
with other known NSAIDs: ketoprofen and ibuprofen (see
Fig. 1). The results obtained might be successfully used dur-
ing the detailed analysis of the possible DCL modifications
with saving its specific bioactivity. Taking into account high
computational cost of an aqueous environment in the present
simulations, we use only gas-phase calculations to establish
the role of intramolecular interactions on the DCL structural
stability.
Computational methods
The main part of the studies performed focuses on the anal-
ysis of the structural stability of DCL molecule using Car–
Parrinello molecular dynamics simulations [23]. Before it,
the geometry optimization of the diclofenac molecule was
performed using density functional theory (DFT) approach
with B3LYP functional and localized basis set 6-31G(d,p)
using Gaussian09 program package [24]. Among 21 calcu-
lated local minima, three DCL structures (see Fig. 2) were
chosen as the initial atomic configurations for the molecu-
lar dynamics (MD) simulations of isolated DCL molecules
in the gas phase. The first structure (A) is the most sta-
ble DCL structure in the gas phase, the second one (B) is
similar to the DCL crystal structure [11], while the third
one (C) is the most unstable structure of diclofenac. MD
simulations were performed according to the Car–Parrinello
scheme [23] using the CPMD program package (version
4.1.0) [25] with the general empirical dispersion correc-
tion (D2) of Stefan Grimme [26]. All calculations were
made utilizing Perdew-Burke-Ernzerhof (PBE) exchange-
correlation functional and the plane-wave (PW) basis set
with the kinetic energy cutoff of 30 Ry. The PBE functional
was previously shown to give the satisfactory precision in
the description of systems with hydrogen bonding [27].
The effective potential of ions was described by Vander-
bilt ultrasoft pseudopotentials [28]. We used the unit cell
of 22.0A˚·22.0A˚·22.0A˚ for periodic boundary conditions to
prevent the interactions between neighbor DCL molecules.
The Poisson equation for isolated system was solved using
Martyna–Tuckerman method [29]. All wavefunctions were
fully converged (1·10−8 a.u.) and the electronic degrees of
freedom were quenched to the Born–Oppenheimer surface
before starting the simulations. We used Nose´–Hoover [30,
31] chain thermostats on ions and electrons in the canonical
ensemble to keep the adiabatic isolation between the ficti-
tious electron and nuclear dynamics. The frequency for the
ionic thermostat was set to 1500 cm−1, while for the elec-
tron thermostat on 10000 cm−1. All simulations were 30 ps
long with the preceded equilibration procedure of 10 ps.
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Fig. 2 Optimized global minimum A (a) and selected local minima B
(b) and C (c) of the diclofenac molecule obtained using DFT static cal-
culations. The NCI surfaces correspond to s = 0.4 a.u. and a color scale
of -0.05 < ρ < 0.05 a.u. The H-bonds (confirmed by QTAIM) and the
C-C-N-C diheral angle are marked in black dash lines and red circles,
respectively
The time step and the fictitious electronic mass of MD sim-
ulations were set to 4 a.u. and 400 a.u., respectively. The
simulations were performed at finite temperature of 300 K.
The systematic description of intramolecular hydrogen
bonds and other noncovalent interactions in diclofenac
was performed using the Quantum Theory of Atoms in
Molecules (QTAIM) [32] and the non-covalent interactions
(NCI) index [33, 34]. For this purpose AIMALL program
(version 13.05.06) [35] and NCIPLOT program (version
3.0) [36] were utilized. The fully converged wavefunctions
of the optimized DCL molecules were generated utilizing
the hybrid PBE functional with empirical dispersion cor-
rection D2 and the localized basis set (aug-cc-pVDZ) using
Gaussian09 package [24]. The QTAIM was used to confirm
quantitatively the existence of hydrogen bonds in DCL by
the analysis of the electron density and its Laplacian at the
bond critical points (BCP). The aim of the NCI index was
to detect qualitively and vizualize hydrogen bonds, vdW
interactions and steric clashes in the molecule on the basis
of the electron densities and their reduced gradients. The
vizualization of the results obtained were made using VMD
program package [37].
The same computational setup was used to analyze
ketoprofen and ibuprofen molecules. Only the frequen-
cies of the thermostats were set to the other values:
1260 cm−1 and 10000 cm−1 for ketoprofen; 3000 cm−1




In the literature, a lot of investigations concerning the
diclofenac interactions with biomolecules, drug modifiers
etc. are present, but only the crystal structure of the DCL
molecule is known [11]. As the result, before the analysis
of the DCL structural stability we have predicted the most
probable drug structure in the gas phase. Figure 2 shows
three of 21 calculated DCL conformers with the correspond-
ing value of their relative energy. We have chosen only three
DCL structures to show the significant structural differences
of different DCL conformers at 300 K using molecular
dynamics simulations (see Section “Molecular dynamics
simulations”). It should be noted that the examined struc-
ture B represents the DCL crystal structure, reported in
Ref. [11]. The only difference between these DCL struc-
tures is the C-C-N-C dihedral angle, which equals to 60.47°
for the calculated structure and 62.60°/62.19° for HD1/HD2
polymorphic DCL forms.
For the best understanding of the influence of the nonco-
valent interactions (NCI) on the defining the drug structure,
the NCI surfaces are shown simultaneously in Fig. 2. To
analyze intramolecular hydrogen bonds in the molecule we
have used two the most popular theoretical techniques: the
Bader analysis [32] and the noncovalent (NCI) index [33].
The first one uses the value of the electron density and
its Laplacian at the bond critical points (BCP) to estimate
the hydrogen bond existence and strength – according to
U. Koch and P. Popelier [38], the hydrogen bond exists if
the electron density is in the range of 0.002–0.035 a.u. and
its Laplacian – 0.024–0.139 a.u. The second one provides
three-dimensional regions around BCPs on the basis of the
sign of second eigenvalue (λ2) of the electron-density Hes-
sian matrix [34] to vizualize both attractive and repulsive
interactions in the real-space. In general, NCI surfaces with
density values in the range of 0.005 < ρ < 0.05 a.u. char-
acterize strong noncovalent interactions, including H-bonds
(negative λ2) and steric clashes (positive λ2). Characteristic
densities of vdW interactions are smaller than H-bonds. Sur-
faces with very low density values (ρ < 0.005 a.u.) shows
the existence of weak dispersion interactions.
From Fig. 2 one can see that the noncovalent interactions
pattern for the DCL conformers is similar. All structures are
characterized by three types of the NCI interactions: hydro-
gen bonds, vdW interactions and steric clashes, which are
mapped in green. For the best analysis of the NCI index,
the relationship between reduced density gradient and the
sign of λ2 is shown in Fig. 3. The DCL global minimum
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Fig. 3 NCI analysis of diclofenac local minima (A, B, C): the
relationship between reduced density gradient (s) and the sign of the
second eigenvalue (λ2) of the electron-density Hessian. Peaks appear
at ρ  –0.05 a.u., ρ  ±0.01 a.u. and ρ  0.05 a.u. characterize
H-bonds, vdW interactions, and steric clashes, respectively
(structure A) possesses two intramolecular hydrogen bonds:
N-H· · · O and N-H· · · Cl, with the H· · · B distance of 2.02 A˚
and 2.56 A˚, respectively. Because of the low linearity of
the N-H· · · Cl hydrogen bond (104.9°), only N-H· · · O H-
bond, with the electron density value of 0.0231 a.u. and its
Laplacian of 0.0673 a.u., was identified using the QTAIM
analysis (see Table 1). As it was suggested in Ref. [8], the
DCL structure is influenced by the repulsion between the
aromatic rings. This fact is also confirmed here due to the
NCI analysis; the repulsion interaction is shown as large
steric clash (in green) in Fig. 2. The strength of these inter-
actions is comparable to the attractive ones, caused by the
hydrogen bonds formation (see the values of the reduced
electron density gradients (s) in Fig. 3). As the result, the
angle of the twist between the DCL phenyl rings, measured
by the value of the C-C-N-C dihedral angle (marked in red
circles), is equal to 58.55°. The structure A is the most
stable one, as the result its relative energy value equals to
0 kcal/mol. The relative energy values for other DCL local
minima were calculated with respect to this structure.
The structure B of the diclofenac molecule is very sim-
ilar to the global minimum structure. The pattern of the
NCI interactions is almost the same, e.g., the structural and
topological parameters of the hydrogen bonds (Table 1)
or NCI parameters (Fig. 3). The only difference between
these two structures is the geometry of the COOH group
with respect to the CH2 fragment and the mutual direc-
tionality of the DCL phenyl rings. It can be easily seen in
Fig. 4, where the superposition of the structures A and B is
shown. Such small structural differences cause the change
of the repulsive wall between the phenyl rings, making the
DCL molecule less stable (it was confirmed during ab ini-
tio molecular dynamics simulations, see Section “Molecular
dynamics simulations”), therefore, the absolute energies of
these structures differ by 6.05 kcal/mol. Additionally, these
differences cause that the DCL structure B is able to inhibit
COX-2 receptor, because such mutual phenyl ring position
of DCL is similar to the COX-2 substate [39]. Therefore,
diclofenac structure bounded to the active site of the enzyme
is similar to the mentioned structure B.
Completely different conformation of the diclofenac
molecule represents the least stable structure (marked as C
in Fig. 2), with the relative energy value of 13.19 kcal/mol.
The superposition between the structures A and C is shown
Table 1 The structural and topological parameters of A-H· · · B hydrogen bonds formed in diclofenac molecule, obtained using DFT static
calculations and the Quantum Theory of Atoms in Molecules
Label Erel H-bond type H· · · B N−H ∠(AHB) QTAIM confirmed ρH ···B ∇2ρH ···B
[ kcal/mol ] [ A˚ ] [ A˚ ] [ ° ] [ a.u. ] [ a.u. ]
A 0.00 N-H· · · O 2.02 +0.018 146.6 + 0.0231 0.0673
N-H· · · Cl 2.56 – 104.9 – – –
B 6.05 N-H· · · O 2.01 +0.019 147.3 + 0.0239 0.0699
N-H· · · Cl 2.59 – 103.0 – – –
C 13.19 C-H· · · O 2.45 – 106.2 + 0.0123 0.0473
N-H· · · Cl 2.45 – 111.1 + 0.0176 0.0628
Relative energies (Erel) are given in kcal/mol. Geometrical parameters: interatomic distances (H· · · B), changes in N-H bond length and valence
angles [∠(AHB)] are given in A˚ and °, respectively. Topological parameters: the electron densities and the Laplacians of the electron densities at
bond critical points (BCPs) of hydrogen bonds are given in a.u.
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Fig. 4 The superposition of the optimized global minimum struc-
ture (A) of the DCL molecule with its structure B and C. The global
minimum structure is marked in purple
in Fig. 4. In comparison to the global minimum, in the
structure C there is no evidence for the formation of the
intramolecular N-H· · · O hydrogen bond, which is the most
characteristic and energetically stable in the case of DCL
molecule. Instead of the strong N-H· · · O H-bond, the weak
C-H· · · O hydrogen bond with the H· · · O distance and CHO
angle of 2.45 A˚ and 106.2°, respectively (see Table 1), is
formed. The strength of the repulsion wall between the DCL
phenyl rings is slightly weaker than in the case of the struc-
tures A and B (see the values of the electron density with
positive sign of λ2 in Fig. 3). As the result, the angle of
the twist between the phenyl rings is smaller and equals
30.87°. There is an extra repulsion between the pheny-
lacetic ring and the secondary amino group, based on the
hydrogen-hydrogen repulsion interactions (see Fig. 2). The
structure C, as A and B, possesses N-H· · · Cl H-bond, but
due to its slightly higher linearity (111.1°), its existence was
confirmed by the QTAIM analysis (see Table 1).
Molecular dynamics simulations
The best way to estimate the structural stability of
diclofenac molecule is to analyze its dynamics using ab
initio molecular dynamics (MD) simulations at finite tem-
perature. In the present work, MD simulations were per-
formed for all previously analyzed DCL conformers (see
Section “Static calculations”) to provide a detailed descrip-
tion of possible DCL structural rearrangements in the
gas phase at 300 K. The selected snapshots illustrating
the DCL conformation at finite time of the simulation
are shown in Fig. 5. As it was mentioned before, the
molecular structure of diclofenac depends on the repul-
sive character of the phenyl rings, which cause the specific
twist between them and enable the formation of additional
intramolecular hydrogen bonds stabilizing the particular
DCL conformation. Consequently, we are analizing DCL
hydrogen bonds breaking and formation to estimate their
impact on the DCL structural rearrangements, which can
be described through the changes of the C-C-N-C dihedral
angle (see Section “Static calculations”).
The DCL global minimum structure (A) is character-
ized with the highest structural stability at 300 K, which
is depicted in the corresponding snapshots in Fig. 5. It can
be confirmed by the analysis of the time evolution of its
C-C-N-C dihedral angle (black curve in Fig. 6), which is
relatively stable during the simulation time. The values of
the C-C-N-C dihedral angle oscillate around 60°, what is
consistent with its value (69° [8] and 62° [11]) obtained
in the X-ray analysis. Such DCL conformation is similar
to the one obtained using static calculations (structure A),
where two hydrogen intramolecular bonds are formed: N-
H· · · O and N-H· · · Cl. The existence of both H-bonds can
be confirmed on the basis of H· · · B distance and AHB
angle, where A-H and B are H-bond donor and acceptor,
respectively. According to the latest IUPAC definition [40]:
the closer the H-bond angle is to 180°, the stronger is the
hydrogen bond and the shorter is the H· · · B distance. More-
over, the preferable value for the AHB angle is more than
110°. Fig. 7 represents changes of the H· · · B distance and
the AHB angle of N-H· · · O and N-H· · · Cl hydrogen bonds
during the MD simulation. The analysis of the radial dis-
tribution function of H· · · B distance indicates the average
H· · · O distance of 2.08 A˚ and H· · · Cl – 2.56 A˚. Both hydro-
gen bonds are stable during the simulation time. N-H· · · O
hydrogen bond is stronger than N-H· · · Cl one.
Even if the first DCL local minimum (structure B)
slightly differs from the structure A in static calculations,
its structural stability at 300 K is definitely different (see
Fig. 5). Apart from the characteristic for diclofenac N-
H· · · O and N-H· · · Cl hydrogen bonds, there are structural
rearrangements caused by the O-H· · · N H-bond formation
(snapshot “1” in Fig. 5) with the maximum lifetime of 1.5 ps
(Fig. 8). This hydrogen bond defines the DCL conforma-
tion during the first 6 ps (see Fig. 6), while no N-H· · · O and
N-H· · · Cl hydrogen bonds are formed. Such formed struc-
ture is not stable, therefore, it changes to the one depicted
in the snapshot “2” in Fig. 5, where the C-C-N-C dihedral
angle equals to c.a. 180°. The lifetime of such DCL con-
formation, without hydrogen bonds formed, is only 1 ps
(Fig. 6). Since c.a. 8 ps DCL rearranges to the structure
shown in the snapshot “3”, which reminds the structure B
in the static calculations. The time evolution of the C-C-N-
C dihedral angle of such DCL conformation (Fig. 6) shows
its relatively high structural stability till the end of the MD
simulation. This structure is defined by intramolecular N-
H· · · O and N-H· · · Cl hydrogen bonds (see black and red
curves in Fig. 8) with the average H· · · B distance of 2.06 A˚
and 2.48 A˚, respectively. Taking into account the COX-2
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global minimum structure of diclofenac molecule(a)
(b)
(c)
local minimum structure of diclofenac molecule
local minimum structure of diclofenac molecule
Fig. 5 Selected snapshots from the Car–Parrinello molecular dynamics simulations of diclofenac global A (a) and local B (b) and C (c) minima
at 300 K. Each snapshot is presented with its time-stamp. The H-bonds and the C-C-N-C diheral angle are marked in black and red, respectively
structure and DCL binding to its active site [39], the struc-
ture B is similar to the DCL structure, which participates in
the inhibition process of the COX-2. Due to higher flexibil-
ity of the N-H· · · O H-bond in the structure B, comparing
to the structure A (see Fig. 10), such DCL conformation
can interact with the COX-2 active site via hydrogen bonds
between DCL carboxyl group and Ser-530/Tyr-385.
The least stable structure in the static calculations (struc-
ture C) is very stable during the first 16 ps of MD simulation
(see Fig. 6). The C-C-N-C dihedral angle, indicating the
twist between the phenyl rings, is close to the one calcu-
lated in Section “Static calculations”. Such structure formed
possesses stable intramolecular N-H· · · Cl hydrogen bond
with the average H· · · Cl distance of 2.43 A˚. Since c.a. 12 ps
of the simulation, temporary O-H· · · N H-bonds with max-
imum lifetime of 1.5 ps are formed (see Fig. 9 and the
snapshot “2” in Fig. 5). Despite the relatively high struc-
tural stability of the analyzed DCL conformation, it changes
the character of its rearrangements, which starts to remind
dynamics of the structure B during it first 6 ps of the
simulation (see Fig. 6). Such newly formed conformation
is stable for c.a. 4 ps. Later, the structure with N-H· · · O
and N-H· · · Cl hydrogen bonds is formed (see the snap-
shot “3” in Fig. 5), which after 2 ps rearranges again to
unstable DCL conformation. Taking into account similar
character of the rearrangements of the structure C (after
Struct Chem
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Fig. 6 Time evolution of the C-C-N-C diheral angle of diclofenac
molecule: global minimum (structure A), marked in black; local
minima (structures B and C), marked in red and green, respectively
16 ps) and the structure B (until 6 ps), one can predict that
in the finite time of the simulation the structure C trans-
forms to B, which differs with the global minimum structure
mainly by the direction of the twist between the DCL phenyl
rings.
The plot of the time evolution of the H· · · B distance
in N-H· · · O H-bond of all examined DCL conformations
is shown in Fig. 10. This intramolecular hydrogen bond is
considered, in the literature, as the most stable and char-
acteristic DCL hydrogen bond [8]. Figure 10 indicates that
N-H· · · O H-bond is not stable in all DCL conformations,
thus, not only this H-bond should be taken into considera-
tion during diclofenac modifications. The highest stability
of this H-bond is seen only in the case of the global
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Fig. 7 Time evolution of H· · · B distance and AHB angle of the N-
H· · · O and N-H· · · Cl hydrogen bonds (marked by black and red,
respectively) in the global minimum structure (A) of diclofenac
molecule
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Fig. 8 Time evolution of H· · · B distance of N-H· · · O, N-H· · · Cl and
O-H· · · N hydrogen bonds (marked by black, red and green, respec-
tively) in the local minimum structure (B) of diclofenac molecule
Comparison of NSAID inhibition activity
Most of chemical and biochemical reactions between a
protein and a drug are controlled by noncovalent interac-
tions, which are dependent on a drug molecular structure.
According to results reported in Ref. [39, 41], depending
on the NSAID structure, different junctions to the COX-2
active site for the inhibitor binding are possible. Most of
the NSAID molecules inhibit COX-2 through the carboxyl
group coordination with Arg-120 and Tyr-355 near the
membrane interface, while the selective COX-2 inhibitors
bind to the enzyme side pocket [39]. Diclofenac shows dis-
tinct pharmacophore behavior [42]. Due to its specific struc-
ture, DCL binds to COX-2 similarly to the non-productive
arachidonic acid (the target substate of COX-2) through
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Fig. 9 Time evolution of H· · · B distance of N-H· · · O, N-H· · · Cl and
O-H· · · N hydrogen bonds (marked by black, red and green, respec-
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Fig. 10 Time evolution of H· · · B distance and AHB angle of N-
H· · · O hydrogen bond in the structure A, B and C of diclofenac
molecule, marked by black, red and green, respectively
the hydrogen bond with Tyr-385 and Ser-530 [39]. There-
fore, its COX-2 inhibition activity was reported to be the
best [3]. The detailed structure of the COX-2 enzyme with
DCL bound to the active site is a supplementary material to
Ref. [39] and can be found in PDB database under the name
of 1PXX. The structure of DCL bounded to COX-2 is simi-
lar to the crystal DCL structure, reported in the present work
as the structure B.
Ibuprofen and ketoprofen are also widely known NSAID
with similar to diclofenac acidity constants: 4.5 and 4.0,
respectively. Moreover, ibuprofen has even similar partition
coefficient of 12.7. But, among these three NSAID rep-
resentatives, only DCL contains phenyl rings twisted with
respect to each other, which enables DCL to possess simi-
lar geometry to the COX-2 substrate. As a result, ketoprofen
and ibuprofen take the eighth and the fourteenth place on
the COX-2 inhibition activity list, mentioned in Ref. [3].
The same trend is present in the case of piroxicam and
phenylbutazone [8].
To compare the structural differences between
diclofenac, ketoprofen and ibuprofen in detail, their global
minimum structures with the NCI surfaces are shown in
Fig. 11. It can be seen that ketoprofen has similar to DCL
structural features, but instead of the chlorinated phenyl
ring, the phenyl ring without substituents is present, and
secondary amino group is changed to carbonyl one. Due
to such changes, there is weaker repulsion wall and lower
angle of a twist between the phenyl rings. Only weak
intramolecular C-H· · · O hydrogen bonds can be formed.
The existence of the C-H· · · O H-bond can be confirmed
due to the NCI index (see lower chart in Fig. 11). The
QTAIM and NCI analysis of the ibuprofen molecule (struc-
ture (c) in Fig. 11) indicate that there is no specific repulsion
in the molecule and no evidence for intramolecular hydro-
gen bonds formation. At the same time, the value of the
C-C-C-C dihedral angle is close to the C-C-N-C observed
in DCL. The structural stability of all these NSAID
molecules was analyzed using ab initio MD at 300 K. The
results obtained showed no significant structural changes
Fig. 11 Optimized global minima of diclofenac (a), ketoprofen (b)
and ibuprofen (c) molecules obtained using DFT static calculations
and the corresponding s(ρ) plots for their SCF density. The NCI
surfaces correspond to s = 0.4 a.u. and a color scale of -0.04 < ρ <
0.04 a.u. The H-bonds (confirmed by QTAIM) and C-C-N-C diheral
angle are marked in black and red dash lines, respectively
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in ibuprofen molecule and higher mobility of the phenyl
ring s in ketoprofen, comparing with DCL. The higher
rotational flexibility of ketoprofen might unable its bonding
with Ser-530, which interacts efficiently with DCL. The
similar dependence was reported by Llorens et al. [42] for
fenoprofen. Therefore, we suggest that the higher inhibi-
tion activity of diclofenac can be explained on the basis
of the existence of intramolecular hydrogen bonds, which
stabilize significantly the drug structure in its preferable,
for COX-2 enzyme, configuration with maximum twist
between the phenyl rings.
Conclusions
We used static DFT calculations and ab initio molecular
dynamics simulations at 300 K to analyze the structural
stability of the diclofenac molecule and estimate its influ-
ence on the drug inhibition activity. Noncovalent interac-
tions, which define the molecular structure of diclofenac,
were identified using the Quantum Theory of Atoms in
Molecules and the NCI index. The existence of intramolecu-
lar hydrogen bonds in diclofenac: N-H· · · O, N-H· · · Cl and
O-H· · · N, was also confirmed. The time-resolved properties
of the most important structural descriptors were presented
and discussed in detail.
The most probable molecular conformation of diclofenac
in the gas phase is the global minimum structure, which is
characterized with high structural stability at 300 K and is
stabilized by intramolecular N-H· · · O and N-H· · · Cl hydro-
gen bonds. However, the DCL global minimum has not
been found during the inhibition process of COX-2 as the
result of the changed mutual orientation of the phenyl rings,
which unable the hydrogen bond formation with Tyr-385
and Ser-530. The structure B, which has been found to bind
to the enzyme active site, is less stable than global minimum
A and represents the crystal DCL structure. It possesses
higher flexibility of the DCL characteristic N-H· · · O hydro-
gen bond, enabling easier coordination of the COX-2 active
site. The lifetime of temporary O-H· · · N hydrogen bond,
which determines some less stable drug rearrangements, is
maximum 1.5 ps.
The direct comparison of the structural stability of
diclofenac and other NSAID molecules (ketoprofen and
ibuprofen) indicate that diclofenac possesses higher COX-2
inhibition activity as the result of effective structure stabi-
lization with intramolecular hydrogen bonds formation and
characteristic repulsion wall enabling the maximum twist
between the drug phenyl rings. These noncovalent interac-
tions ensure the DCL molecule to have geometry similar
to the non-productive arachidonic acid, which is the sub-
strate of COX-2. Thus, diclofenac inhibits COX-2 in the
orientation that prevent interactions with Arg-120, which
are present during the COX-2 inhibition by other NSAID.
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